Business
AREV SUES HARVEY FOR BREACH OF CONTRACT
AREV SUES HARVEY FOR BREACH OF CONTRACT.
About this update from Arev Life Sciences Global Corp.
[{"type":"text","content":"VANCOUVER, BC / January 31, 2020 / AREV BRANDS INTERNATIONAL LTD. (CSE: AREV) (OTC: AREVF) (“AREV Brands”) announces the Company has commenced litigation in the Supreme Court of British Columbia over the breaches of Agreement by the Defendant, Matthew Harvey, the vendor of the BC Bud Depot Assets.On July 3, 2018 AREV entered into an asset purchase agreement to purchase the assets of BC Bud Depot (see Arev’s July 12, 2018 news release). The Company claims Mr. Harvey has breached the contract and is seeking relief. Mr. Harvey has 21 days to respond from the date of service. The company has no guarantee of succeeding and no estimate of when this matter will be resolved; however, the Company’s litigator remains confident that the Company has strong case.Mike Withrow, CEO stated, “Relief being sought is to protect AREV shareholders. This is now in the court and management is committed to vigorously pursuing this matter. We strongly disagree with the content in the recent news issued January 30 by Mr. Harvey, doing business as BC Bud Depot.”For further information, contact Mike Withrow, [email protected] 778-929-6536.On behalf of the Board,Mike WithrowCEO & DirectorAbout AREV Brands International Ltd. AREV Brands International Ltd. (“AREV”) produces and delivers functional compounds and ingredients derived from verified genetics ran through its world-class extraction systems. AREV is revolutionizing the current delivery method of terpenes, cannabinoids and flavonoids. These premium ingredients and formulations are used in products targeted for sale in the natural health, medical, functional food, nutraceutical, sport nutrition and bioceutical markets. AREV innovates through extraction to produce extracts from specific selected plant and exude from trees that address 5 areas of health including Anxiety, Pain Management, Insomnia, Central Nervous System Disorders & Libido.NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.FORWARD LOOKING INFORMATIONNeither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. This news release may include forward-looking statements that are subje...